IFG
PPH icon

Independent Financial Group’s VanEck Pharmaceutical ETF PPH Stock Holding History

Independent Financial Group’s Portfolio PPH Stock Details PPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$591K Buy
5,402
+29
+0.5% +$3.23K 0.01% 919
2026
Q2 		$588K Buy
5,373
+255
+5% +$26.4K 0.01% 921
2026
Q1 		$532K Buy
5,118
+84
+2% +$8.95K 0.01% 907
2025
Q4 		$519K Sell
5,034
-183
-4% -$17.8K 0.01% 880
2025
Q3 		$471K Buy
5,217
+8
+0.2% +$701 0.01% 883
2025
Q2 		$458K Sell
5,209
-492
-9% -$42.6K 0.01% 814
2025
Q1 		$520K Buy
5,701
+78
+1% +$7.03K 0.02% 694
2024
Q4 		$485K Buy
5,623
+1,668
+42% +$151K 0.02% 702
2024
Q3 		$376K Sell
3,955
-142
-3% -$13.5K 0.01% 776
2024
Q2 		$375K Sell
4,097
-552
-12% -$49.3K 0.02% 733
2024
Q1 		$422K Buy
4,649
+1,341
+41% +$117K 0.02% 643
2023
Q4 		$269K Buy
3,308
+290
+10% +$22.7K 0.01% 766
2023
Q3 		$241K Buy
3,018
+390
+15% +$31.4K 0.02% 761
2023
Q2 		$207K Buy
+2,628
New +$206K 0.01% 805

Other funds holding PPH

RBC
Rye Brook Capital Greenwich, Connecticut $154M AUM 17.54% 1-Year Est. Return
WWM
WT Wealth Management Scottsdale, Arizona $357M AUM 15.82% 1-Year Est. Return
FF
Fluent Financial Dallas, Texas $292M AUM 8.92% 1-Year Est. Return
AWM
Avior Wealth Management Omaha, Nebraska $3.79B AUM 15.36% 1-Year Est. Return
IPAM
Investment Partners Asset Management Metuchen, New Jersey $186M AUM 19.73% 1-Year Est. Return
VIP
Value Investment Professionals New York $115M AUM 13% 1-Year Est. Return
EFG
Elm3 Financial Group Alpharetta, Georgia $150M AUM 21.63% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
BWM
Bullock Wealth Management Bloomington, Indiana $241M AUM 23.31% 1-Year Est. Return
TC
Trust Company Manhattan, Kansas $1.15B AUM 7.83% 1-Year Est. Return

Independent Financial Group's PPH Position: Q3 2026 in Review

Independent Financial Group increased its VanEck Pharmaceutical ETF (PPH) stake by 0.54% in Q3 2026, buying an estimated $3.23K and bringing the position to 5,402 shares worth $591K. The position accounts for 0.01% of the portfolio, ranked #919.

Independent Financial Group first reported a position in PPH in Q2 2023 and has held it in 14 quarters since. 11 funds tracked by Wall St. Rank hold PPH as of Q3 2026.

  • Independent Financial Group held 5,402 shares of VanEck Pharmaceutical ETF worth $591K as of Q3 2026.
  • Independent Financial Group bought 29 VanEck Pharmaceutical ETF shares in Q3 2026, an estimated $3.23K.
  • VanEck Pharmaceutical ETF made up 0.01% of Independent Financial Group's portfolio in Q3 2026, its #919 holding.
  • Independent Financial Group first reported a position in VanEck Pharmaceutical ETF in Q2 2023 and has held it in 14 quarters since.
  • 11 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q3 2026.

Based on Independent Financial Group's 13F filing for Q3 2026, filed 13 Oct 2026.